Home/Filings/4/0001140361-18-008682
4//SEC Filing

LESCHLY JAN 4

Accession 0001140361-18-008682

CIK 0000072444other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:25 PM ET

Size

6.8 KB

Accession

0001140361-18-008682

Insider Transaction Report

Form 4
Period: 2018-02-13
LESCHLY JAN
Director10% Owner
Transactions
  • Award

    Common Stock

    2018-02-13+30,793,67030,793,670 total(indirect: See Footnote)
Footnotes (2)
  • [F1]Consists of 30,793,670 aggregate shares of Aviragen Therapeutics, Inc. ("Aviragen") common stock received by Care Capital Investments III, LP ("Investments III") and Care Capital Offshore Investments III, LP ("Offshore III") upon conversion of shares of Vaxart, Inc. ("Vaxart") in connection with the merger of Vaxart into Agora Merger Sub, Inc., a wholly owned subsidiary of Aviragen (the "Merger"). In connection with the closing of the Merger, each share of Vaxart common stock was converted into 0.2211 shares of Aviragen common stock. On the closing date of the Merger, the closing price of Aviragen's common stock was $0.82 per share. Following the Merger, Aviragen effected a reverse stock split at a ratio of one new share for every eleven shares of Aviragen common stock outstanding. The effects of such reverse stock split is not reflected here.
  • [F2]Consists of (i) 30,287,856 shares held by Investments III and (ii) 505,814 shares held by Offshore III. Care Capital III LLC is the general partner of Investments III LP and Offshore III (collectively, "Care Capital") and as a result, Care Capital III LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. The reporting person, Richard Markham, Jerry N. Karabelas and David R. Ramsay are the four managing members at Care Capital III LLC, and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by Care Capital. The reporting person is a managing member of Care Capital III LLC, and serves as a representative of Care Capital on Aviragen's board of directors. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Vaxart, Inc.

CIK 0000072444

Entity typeother

Related Parties

1
  • filerCIK 0001204568

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:25 PM ET
Size
6.8 KB